Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer
Clinical trial NCT07166185 · RECRUITING
Trial details
- NCT number
- NCT07166185
- Sponsor
- Blida 1 University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-01
- Primary completion
- 2025-10-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.